forecast

Early Amyloid Clearance Could Slow Decline

Late-stage anti-amyloid drugs from Biogen and Eli Lilly slow cognitive decline by about 30 percent, and earlier treatment could reduce decline rates by 40 to 50 percent or more, potentially enabling a world without Alzheimer's.

forecastpending

Speaker

Alex

Evidence Quote

“we can slow that decline by about 30%”

Source

Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the Best
Created: 11/14/2026, 4:24:39 AM

Your notes

Loading notes...